Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
XBiotech Inc. (XBIT)
:XBIT
Holding XBIT?
Track your performance easily
XBIT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.51 - $9.96
Previous CloseN/A
Volume27.99K
Average Volume (3M)87.29K
Market Cap
$115.84M
Enterprise ValueN/A
Total Cash (Recent Filing)$34.32M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.16
Next EarningsN/A
EPS EstimateN/A
Last Dividend Ex-Date
Jul 15, 2021Dividend YieldN/A
Share Statistics
EPS (TTM)-1.07
Shares Outstanding30,483,480
10 Day Avg. Volume56,649
30 Day Avg. Volume87,289
Standard Deviation0.20
R-Squared0.15
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-5.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
XBiotech News
PremiumCompany Announcements
XBiotech Appoints Renowned Scientist to Board of Directors
Ownership Overview
43.23%
Insiders
5.79% Mutual Funds
0.04% Other Institutional Investors
44.43% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
XBIT FAQ
What was XBiotech Inc.’s price range in the past 12 months?
XBiotech Inc. lowest stock price was $3.51 and its highest was $9.96 in the past 12 months.
What is XBiotech Inc.’s market cap?
XBiotech Inc.’s market cap is $115.84M.
When is XBiotech Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were XBiotech Inc.’s earnings last quarter?
XBiotech Inc. released its earnings results on Mar 14, 2019. The company reported -$0.17 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.17.
Is XBiotech Inc. overvalued?
According to Wall Street analysts XBiotech Inc.’s price is currently Overvalued.
Does XBiotech Inc. pay dividends?
XBiotech Inc. pays a Notavailable dividend of $2.5 which represents an annual dividend yield of N/A. See more information on XBiotech Inc. dividends here
What is XBiotech Inc.’s EPS estimate?
XBiotech Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does XBiotech Inc. have?
XBiotech Inc. has 30,483,480 shares outstanding.
What happened to XBiotech Inc.’s price movement after its last earnings report?
XBiotech Inc. reported an EPS of -$0.17 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of XBiotech Inc.?
Among the largest hedge funds holding XBiotech Inc.’s share is Caxton Associates LP. It holds XBiotech Inc.’s shares valued at 0.
---
XBiotech Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-21.56%
12-Months-Change
Fundamentals
Return on Equity
-15.75%
Trailing 12-Months
Asset Growth
-8.60%
Trailing 12-Months
Company Description
XBiotech Inc.
XBiotech, Inc. is a biopharmaceutical company, which engages in development and commercialization of therapeutic antibodies based on its True Human™ proprietary technology. Its product pipeline include oncology, infectious diseases, dermatology, and inflammatory disorders. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.
---
Technical Analysis
Adaptimmune Therapeutics
―
Arcutis Biotherapeutics
―
CytomX Therapeutics
―
Fate Therapeutics
―
Kura Oncology
―
---